EFSA approves another algal DHA for use in infant formula
The India-based biopharmaceutical firm secured the approval for its proprietary microalgae pressure, Schizochytrium sp. ATCC-20889, recognized for its capacity to supply excessive quantities of omega-3 polyunsaturated fatty acids, notably DHA.“Because of this EFSA approval, Bioplus will now change into one...